Lu Qi, Zhang Zhiqiang, Xiao Meizhu, Liu Chongdong, Zhang Zhenyu
Department of Obstetrics and Gynecology, Chao-yang Hospital, Capital Medical University, Beijing, People's Republic of China.
Onco Targets Ther. 2019 Sep 26;12:7941-7947. doi: 10.2147/OTT.S224525. eCollection 2019.
The objective of this study was to evaluate the surgical morbidity and oncological outcome of total laparoscopic radical trachelectomy (TLRT) and total laparoscopic radical hysterectomy (TLRH) in patients with early-stage cervical cancer.
We performed a retrospective study to compare the outcomes of patients with stage IB1 cervical cancer who underwent TLRT to patients treated with TLRH from January 2005 to December 2016.
Forty-six patients underwent TLRT and 73 patients underwent TLRH between January 2005 and December 2016. The median age was 30 (19-40) years for TLRT group compared to 43 (31-65) years for TLRH group. No significant difference was found for the tumor size, histology, and pathology grade between TLRT group and TLRH group. In the TLRT group, the median operative time was 200 mins (range, 150-360 mins) and the median blood loss was 200 mL (range, 50-400mL). In the TLRH group, the median operative time was 240 mins (range, 180-380) and the median blood loss was 250mL (range, 10-1500mL). The median follow-up time was 80 months for TLRT group and 72 months for TLRH group. No patient in TLRT group developed recurrence. However, there were 2 recurrences diagnosed in the TLRH group.
TLRT appears to have equal surgical morbidity and oncological outcome to TLRH in stage IB1 cervical cancer. Intraoperative complications did not differ significantly between these two groups. However, postoperative complications were fewer observed in TLRT. Because of the natural limitations of the retrospective study, the clinical value should be confirmed by multi-institutional prospective trial in the future.
本研究旨在评估早期宫颈癌患者行全腹腔镜根治性宫颈切除术(TLRT)和全腹腔镜根治性子宫切除术(TLRH)后的手术并发症及肿瘤学结局。
我们进行了一项回顾性研究,比较2005年1月至2016年12月期间接受TLRT的IB1期宫颈癌患者与接受TLRH治疗的患者的结局。
2005年1月至2016年12月期间,46例患者接受了TLRT,73例患者接受了TLRH。TLRT组的中位年龄为30(19 - 40)岁,TLRH组为43(31 - 65)岁。TLRT组和TLRH组在肿瘤大小、组织学和病理分级方面未发现显著差异。TLRT组的中位手术时间为200分钟(范围150 - 360分钟),中位失血量为200毫升(范围50 - 400毫升)。TLRH组的中位手术时间为240分钟(范围180 - 380),中位失血量为250毫升(范围10 - 1500毫升)。TLRT组的中位随访时间为80个月,TLRH组为72个月。TLRT组无患者复发。然而,TLRH组有2例复发被诊断出。
在IB1期宫颈癌中,TLRT似乎与TLRH具有相同的手术并发症及肿瘤学结局。两组术中并发症无显著差异。然而,TLRT术后并发症较少。由于回顾性研究的天然局限性,其临床价值未来应通过多机构前瞻性试验来证实。